Diagnostic Value of Serum YKL‐40 Level for Coronary Artery Disease: A Meta‐Analysis
Authors:
Open Access
- 2 October 2014
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 30 (1) , 23-31
Abstract
Objective: This meta‐analysis aimed to identify the value of serum YKL‐40 level for the diagnosis of coronary artery disease (CAD).Methods: Through searching the following electronic databases: the Cochrane Library Database (Issue 12, 2013), Web of Science (1945∼2013), PubMed (1966∼2013), CINAHL (1982∼2013), EMBASE (1980∼2013), and the Chinese Biomedical Database (CBM; 1982∼2013), related articles were determined without any language restrictions. STATA statistical software (Version 12.0, Stata Corporation, College Station, TX) was chosen to deal with statistical data. Standard mean difference (SMD) and its corresponding 95% confidence interval (95% CI) were calculated.Results: Eleven clinical case‐control studies that recruited 1,175 CAD patients and 1,261 healthy controls were selected for statistical analysis. The main findings of our meta‐analysis showed that serum YKL‐40 level in CAD patients was significantly higher than that in control subjects (SMD = 2.79, 95% CI = 1.73∼3.85, P < 0.001). Ethnicity‐stratified analysis indicated a higher serum YKL‐40 level in CAD patients than control subjects among China, Korea, and Denmark populations (China: SMD = 2.97, 95% CI = 1.21∼4.74, P = 0.001; Korea: SMD = 0.66, 95% CI = 0.17∼1.15, P = 0.008; Denmark: SMD = 1.85, 95% CI = 1.42∼2.29, P < 0.001; respectively), but not in Turkey (SMD = 4.52, 95% CI = –2.87∼11.91, P = 0.231).Conclusion: The present meta‐analysis suggests that an elevated serum YKL‐40 level may be used as a promising diagnostic tool for early identification of CAD.Keywords
Funding Information
- National Nature Science Foundation of China (51103059)
- National Natural Science Foundation of Jilin Province (20140101054JC, 201115071)
- Jilin Industrial Technology Research and Development Project (2013C023-3)
This publication has 34 references indexed in Scilit:
- Coronary Artery DiseaseJournal of Atherosclerosis and Thrombosis, 2014
- Inflammation in AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Potential association between coronary artery disease and the inflammatory biomarker YKL-40 in asymptomatic patients with type 2 diabetes mellitusCardiovascular Diabetology, 2012
- Can YKL-40 be a new inflammatory biomarker in cardiovascular disease?Immunobiology, 2012
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Plasma YKL-40: A Potential New Cancer Biomarker?Future Oncology, 2009
- YKL-40, a secreted glycoprotein, promotes tumor angiogenesisOncogene, 2009
- Effect of Variation inCHI3L1on Serum YKL-40 Level, Risk of Asthma, and Lung FunctionNew England Journal of Medicine, 2008
- HEGESMA: genome search meta-analysis and heterogeneity testingBioinformatics, 2005
- Molecular Characterization of the Gene for Human Cartilage gp-39 (CHI3L1), a Member of the Chitinase Protein Family and Marker for Late Stages of Macrophage DifferentiationGenomics, 1997